A Trial of the Combination of SHR-A1811 and Fluzoparib in HER2-Expressing Cancers
Clinical trial NCT05349409 · UNKNOWN
Trial details
- NCT number
- NCT05349409
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-09
- Primary completion
- 2024-11-30
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.